We are a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors (GPCRs) to address unmet medical needs.

Research Grants show all

NIH1

Publications show all

Arena Pharmaceuticals has published 99 articles.

Patents show all

256Applications197Issued

Clinical Trials show all

13Phase 210Phase 13Phase 3

SEC Filings show all

8-K26110-Q5210-K17D2S-11

SEC Form D Funding Events

DateOfferedSoldType
2010-06-21$35,530,000$35,530,000Equity
2009-07-21$151,760,000$151,760,000Option to Acquire, Security to be Acquired

Key Executives

  • Jack Lief
    Executive Officer, Director
  • K.a. Ajit-simh
    Executive Officer
  • Dominic P. Behan
    Executive Officer, Director
  • Robert E. Hoffman
    Executive Officer
  • William R. Shanahan, Jr.
    Executive Officer
  • Steven W. Spector
    Executive Officer
  • Donald D. Belcher
    Director
  • Scott H. Bice
    Director
  • Harry F. Hixson, Jr.
    Director
  • J. Clayburn La Force, Jr.
    Director
  • Tina S. Nova
    Director
  • Phillip M. Schneider
    Director
  • Christine A. White
    Director
  • Randall E. Woods
    Director